These studies are investigating psychosocial and individual meaning-centered psychotherapy interventions for patients with cancer and bereaved parents. They are sponsored by Memorial Sloan Kettering Cancer Center and are currently recruiting participants. The studies are listed on the ClinicalTrials.gov website.

Study Title: Attention and Interpretation Modification (AIM) for Fear of Breast Cancer Recurrence: An Intervention Development Study

Study Sponsor and Collaborators: Memorial Sloan Kettering Cancer Center; Brown University, Weill Medical College of Cornell University, Wake Forest School of Medicine, and McLean Hospital

Purpose: To customize and personalize an existing computer-based intervention program to help breast cancer survivors cope with fears of cancer recurrence

Ages Eligible for Study: 18 years and older

Genders Eligible for Study: Female

Accepts Health Volunteers: No

Primary Outcome Measures: Develop and refine materials (time frame: 1 year)

Principal Investigator: Wendy Lichtenthal, PhD, Memorial Sloan Kettering Cancer Center. Contact: Elizabeth Slivak, 646-888-0134

For More Information: Visit ClinicalTrials.gov and refer to this study by its identifier: NCT01517945

Study Title: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese

Study Sponsor and Collaborators: Memorial Sloan Kettering Cancer Center; Queens Cancer Center of Queens Hospital, Charles B. Wang Community Health Center, ACS Asian Initiatives, New York Coalition for Asian American Mental Health, and New York Hospital Queens

Purpose: To modify individual meaning-centered psychotherapy to meet the needs of Chinese patients with cancer. Meaning-centered counseling aims to teach patients with cancer how to maintain or increase a sense of meaning and purpose in their lives despite their cancer diagnosis.

Ages Eligible for Study: 21 to 80 years

Genders Eligible for Study: Both

Accepts Health Volunteers: No

Primary Outcome Measures: Adapt the individual meaning-centered psychotherapy intervention (time frame: 2 years)

Principal Investigator: Jennifer Leng, MD, MPH, Memorial Sloan Kettering Cancer Center; 646-888-4243

For More Information: Visit ClinicalTrials.gov and refer to this study by its identifier: NCT02112188

Study Title: Development of Psychotherapeutic for a Parent Who Lost a Child to Cancer

Study Sponsor and Collaborators: Memorial Sloan Kettering Cancer Center, University of Memphis, University of Hawaii, Adelphi University, Weill Medical College of Cornell University

Purpose: To study a new counseling program for parents who have lost a child to cancer

Ages Eligible for Study: N/A

Genders Eligible for Study: Both

Accepts Health Volunteers: Yes

Primary Outcome Measures: Feasibility (time frame: 4 years)

Principal Investigator: Wendy Lichtenthal, PhD, Memorial Sloan Kettering Cancer Center. Contacts: Corinne Sweeney, MA, 646-888-0134; Polly Korbel, BA, 646-888-0129; Wendy Lichtenthal, PhD, 646-888-4812

For More Information: Visit ClinicalTrials.gov and refer to this study by its identifier: NCT02153619 ■